Mesirow Financial Investment Management, Inc. / CSTL
Mesirow Financial Investment Management, Inc.’s Castle Biosciences Inc Position
Does Mesirow Financial Investment Management, Inc. own Castle Biosciences Inc (CSTL)? Not currently — the last reported position was 14.4K shares worth $327,872 in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$327,872
Q1 2023
Shares
14.4K
% of Portfolio
+1.36%
Quarters Held
11
position exited
Position History CSTL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2023 | 14.4K | $327,872 | +1.36% |
| Q3 2022 | 8.0K | $208,000 | +0.99% |
| Q1 2022 | 8.0K | $358,000 | +1.21% |
| Q4 2021 | 8.0K | $341,000 | +0.98% |
| Q3 2021 | 8.0K | $529,000 | +1.56% |
| Q2 2021 | 8.2K | $600,000 | +1.53% |
| Q1 2021 | 8.1K | $558,000 | +1.52% |
| Q4 2020 | 8.3K | $561M | +1.77% |
| Q3 2020 | 8.3K | $427,000 | +1.83% |
| Q2 2020 | 8.2K | $311,000 | +1.46% |
| Q4 2019 | 15.5K | $531,000 | +2.24% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mesirow Financial Investment Management, Inc.’s full portfolio or all institutional holders of CSTL.